Transcriptomics

Dataset Information

0

SUMOylation inhibition potentiates CAR T activity against Multiple Myeloma (scRNA-Seq)


ABSTRACT: Chimeric antigen receptor (CAR)-T cell therapy has shown remarkable clinical efficacy against hematologic malignancies; however, tumor relapse occurs commonly due to T cell dysfunction presenting as exhaustion and loss of effector function. Here, we identified SUMOylation inhibition promoted T cell effector function and prevented T cell exhaustion. Combination of SUMO E1 inhibitor TAK-981, significantly potentiated CAR T cell anti-tumor activity and improved persistence of CAR-presenting T cells in vivo, presenting a potent novel therapeutic approach.

ORGANISM(S): Homo sapiens

PROVIDER: GSE272474 | GEO | 2024/07/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-07-18 | GSE272300 | GEO
2024-04-24 | GSE185841 | GEO
2022-01-10 | PXD024521 | Pride
2022-01-11 | GSE189576 | GEO
2023-08-29 | GSE212330 | GEO
2024-02-28 | GSE255279 | GEO
2024-02-02 | GSE254913 | GEO
2024-09-02 | GSE212446 | GEO
2021-12-31 | GSE163682 | GEO
2021-04-23 | GSE173116 | GEO